Jonah Librach

Figure making and auditing is too easy on sciugo.com #SciComm @MicrobiomDigest #ImageForensics

1 billion cells. One atlas. Today, Illumina introduces the Billion Cell Atlas, creating the most comprehensive map of human disease biology — and unlocking unparalleled speed and scale in AI for drug discovery. The Atlas will help researchers, including founding participants @AstraZeneca, @Merck, and @EliLillyandCo study the effect of switching on and off all 20,000 genes in cells linked to diseases that have been historically difficult to decode. Learn how the Atlas will elucidate the biological pathways behind some of the world’s most devastating diseases: illumina.com/company/news-c… #JPM2026

@garrytan For loops are slow

Solvable with one for loop and one if statement

Figure making and auditing is too easy on sciugo.com #SciComm @MicrobiomDigest #ImageForensics

@StephAngers, still overrated? 😂

@MartinKulldorff @RCJAPH Peer review should be nearly automated. Anything less is inadequate.

Peer review is fundamental to science and reviewers should be paid. Our new open access and open peer review Journal of the Academy of Public Health (@RCJAPH) does that. If you agree, check it out and sign up to review! publichealth.realclearjournals.org

@NerdyCammy @haesleinhuepf @tischitischer @petebankhead @cmci_ @CiminiLab @FijiSc Fiji could use a revamp

Answering the call of @haesleinhuepf, @tischitischer,@petebankhead,@cmci_,@CiminiLab My @FijiSc training notes are now FAIR. All online in an open format to download and use for teaching, training and other things. All in Google Doc or PDF formats bit.ly/4hkfEBF

Announcing another multi-launch contract on the books with Electron for Japanese constellation operator @QPS_Inc 🚀🚀🚀🚀 Across three missions this year and a fourth in 2026, Electron will help build out iQPS' sythentic aperture radar constellation collecting Earth imagery. Constellation deployment requires launch reliability, flexibility, and precise delivery of satellites to their chosen orbit. That's a service we're proud to support iQPS with on Electron. Learn more: bit.ly/4hosI99

Two launches in less than 24 hours from two pads in two different hemispheres.

A nanobot helping a sperm with motility issues along towards an egg. These metal helixes are so small they can completely wrap around the tail of a single sperm and assist it along its journey

@mbeisen @HalieyWelchX She’s an agent for the mossad, this has been known for a long time m.jpost.com/omg/article-82…

Has @HalieyWelchX considered becoming the SOHCAHTOA girl?

@elonmusk Hi Elon

Exactly

@TD_Canada why is webbroker not working, I can't access holdings

@AMelhede Interesting thoughts – I'm working on something similar. Would be good to connect

DeSci is not innovative enough We are seeing a lot of copying in DeSci and a genuine lack of innovation. Trying new things is key for progress and DeSci is no different. If everyone is doing the same thing, how can we create dramatically more value rather than just compete for the total value already created? The industry is fundamentally nascent and this means that there is plenty of room for iteration. Even if one formula might have worked, does that mean it will work forever? Probably not. And, keep in mind, that not 1 DeSci project has achieved scale and a meaningful scientific breakthrough YET. So, why are we not innovating more? There could be a few reasons for this: 1. Trying new things can be risky 2. Things are progressing, so why innovate? 3. We have already innovated a lot 4. We are seeing echo-chamber behavior 5. Lack of critical thinking But there hasn't been 1 project achieving profitability yet, which is ultimately the goal of any organization. Maybe, we are waiting for a scientific project to advance to a scale where another biotech company or a pharmaceutical company buys the IP. But could this be an even greater risk than merely innovating further? No matter how promising pre-clinical data might be, the further along a research project is, the more risky it becomes. That is why we have the translational gap. Pharma wants to avoid risk and DeSci is supposed to take on that risk to advance a given scientific field. So, if we are not promoting risky behavior, AKA innovation in DeSci, we are promoting the exact actions that created the valley of death in the first place. We need meaningful scientific discoveries to show that DeSci is not just hype but innovative science happening collaboratively, faster, cheaper, and more transparently. Do we need an innovation hub that constantly spits out new ideas for testing? Proper innovation comes from testing out small and then rolling out big. We shouldn’t put all of our eggs in one basket, just like we don’t want to bet everything on 1 research project, which is exactly why most biotech organizations fail. If 10 innovative experiments don’t work out, but the 11th ends up providing a 10x return, isn’t it worth the risk?

@metapredict @slavov_n Why would they be? They authors aren’t liable. It’s the institutions… at least in the US.

@slavov_n Note one of the articles had some deeply flawed informatics. Wrote to the Japan authors but got no reply - they weren't interested in their calculation errors.

Clear interpretations require good experimental designs & metrics.

@lhinderling This is awesome. Would love to learn more about your work.

still learning how to explore these large microsopy datasets. new trick: letting claude write small interactive UIs, customized to our data. happy to hear your tips!!

New Finding of Research Misconduct: Arunoday K. Bhan, Ph.D. View the case summary here: ori.hhs.gov/content/case-s… #ResearchMisconduct #Falsification #Fabrication #Plagiarism

@gymrat7987 It’s nobody’s fault. It’s just supply and demand. Society has yet to improve upon what today’s journals offer

@jonahlibrach Publishing being the way it is, is the journal's fault. Not scientists

I am willing to publish my two 2018 papers on the world first gene edited babies, however it must be published in either Nature or Science. It is one of the greatest medical breakthroughs in history, it deserves the honor to be published in Nature or Science.

@RichardHanania @Jiankui_He This is essentially what every scientist does, ever.

@Jiankui_He So you’ll just hide the knowledge from the world if it can’t get into a good enough journal?

@parambulat0r Interested in this. Please connect w me

Try it out here: plateplanner.nitro.bio The free tier of the application has powerful features like: Excluding Edge Wells: avoid edge effects by excluding the outermost wells on your plate. Intuitive Layout Tools: Quickly lay out your samples with autocomplete and an intuitive interface. Easy Export: After you lay out your plate, preview your table and then export to csv.

I'm excited to launch the free tier of PlatePlanner! PlatePlanner is a tool for research scientists that helps them quickly create beautiful platemaps.

@NatalieTurnerAu @ResearchGate Congrats! Many more to come